ABSTRACT: A new cytotoxic and antiviral cyclic tetrapeptide, asperterrestide A (1), a new alkaloid, terremide C (2), and a new aromatic butenolide, aspernolide E (3), together with 10 known compounds were isolated from the fermentation broth of the marine-derived fungus Aspergillus terreus SCSGAF0162. Their structures were elucidated by spectroscopic analysis, and the absolute configuration of 1 was determined by the Mosher ester technique and analysis of the acid hydrolysates using a chiralphase HPLC column. Compound 1 contains a rare 3-OH-N-CH 3 -Phe residue and showed cytotoxicity against U937 and MOLT4 human carcinoma cell lines and inhibitory effects on influenza virus strains H1N1 and H3N2.
M
arine microorganisms have proved to be an important source of pharmacologically active metabolites, and a growing number of marine-derived fungi have been reported to produce metabolites with unique structures and interesting biological activities. 1 The genus Aspergillus (Moniliaceae), with over 180 species, has attracted considerable attention as a rich source of alkaloids, terpenoids, xanthones, and polyketides, some of which showed antifungal, antibacterial, antifouling, and cytotoxic activities. 2−4 Aspergillus terreus is commonly isolated from soil with worldwide distribution and has been found to produce a number of bioactive compounds, such as terreineol, 5 terrain, 6 aspulvinone, 7 butyrolactone I, 8 and terreic acid. 9 With the aim of searching for novel bioactive natural compounds from marine fungi, we investigated the chemical constituents of a fermentation broth of the marine-derived fungal strain A. terreus SCSGAF0162. Three new compounds, the cyclic tetrapeptide asperterrestide A (1), the alkaloid terremide C (2) , and the aromatic butenolide aspernolide E (3), together with 10 known compounds, methyl 3,4,5-trimethoxy-2-(2-(nicotinamido)benzamido)benzoate (4), 10 butyrolactone I, 8 butyrolactone III, 11 butyrolactone II, 8 4-(4-hydroxyphenyl)-5-(4-hydroxyphenylmethyl)-2-hydroxyfuran-2-one, 12 territrem C, 13 arisugasin H, 14 arisugasin D, 14 territrem B, 13 and territrem A, 13 were isolated. Compound 1 was tested for its cytotoxicity toward human carcinoma U937, K562, BGC-823, MOLT-4, MCF-7, and A549 cell lines and antiviral activity toward two influenza virus strains.
Asperterrestide A (1) was obtained as a yellowish powder. It was assigned a molecular formula of C 26 H 32 N 4 O 5 on the basis of its HRESIMS data. Analysis of the 1 H and 13 C NMR spectra (Table 1) revealed the presence of three amide N-H protons (δ H 6.48, 7.18, and 9.17), four methyl groups (including one Nmethyl), one methylene group, two phenyl rings, five methines (four of which were bound to heteroatoms), and four carbonyl carbons. Interpretation of the 1 H, 13 C, and 2D NMR data of 1 suggested a peptidic nature for the molecule. By analysis of the COSY and HMBC spectra of 1, the aromatic protons at δ and alanine (Ala) were completely assigned. Specifically, the loss of Ala (m/z 71) and Ile (m/z 113) fragments was deduced from the ESIMS 2 spectrum (Supporting Information). Upon extensive analysis of these data, asperterrestide A (1) was assigned as a cyclic tetrapeptide containing ABA, 3-OH-N-MePhe, Ile, and Ala.
The amino acid sequence of 1 was deduced from NOESY correlations between α-protons and neighboring residue NH groups, with support from HMBC correlations. The N-H proton of ABA (δ H 9.17) showed an HMBC correlation with the carbonyl carbon of C-8, indicating that it was acylated by 3-OH-N-Me-Phe, and this connection was also confirmed by the NOESY correlation between the N-H of ABA and H-9 ( Figure  1 ). An HMBC correlation from H 3 -17 to C-18 supported the connection of Ile and 3-OH-N-Me-Phe. HMBC correlations from the N-H proton (δ H 7.18) and H-19 of Ile to C-24, together with the NOESY correlation between H-25 and the N-H proton of Ile, supported the connection of the Ile and Ala residues. The HMBC correlation from the N-H proton (δ H 6.48) of Ala to C-1 supported the connection of Ala and ABA residues. Therefore, the complete sequence of 1 was deduced.
The large coupling constant (J = 10.0 Hz) between H-9 and H-10 of the β-hydroxy-N-Me-phenylalanine residue suggested a syn relative configuration for the two protons. 15 A molecular modeling experiment and the observation of NOE correlations of H 3 -17 with H-10 and of H-9 with N-H (ABA) in the NOESY spectrum of 1 ( Figure 1 ) further confirmed this deduction. The geometries for modeling were obtained in Chem3D 11.0 and then optimized at the AM1 level using Gaussian 09. 16 The absolute configurations of the Ala and Ile residues were determined by analysis of acid hydrolysates on a chiral-phase HPLC column 17, 18 and Marfey's methods. 19, 20 HPLC analyses of the mixture of hydrolysates and authentic samples (co-injection) confirmed D-Ala in 1. Through a chiralphase HPLC analysis, the D-Ile and D-allo-Ile residues could not be differentiated because the retention times of these two compounds were identical. D-Ile and D-allo-Ile were not resolved even using Marfey's method. 21 The absolute configuration of C-10 in 1 was determined using the modified Mosher's ester method in an NMR tube. 22 Compound 1 79) and C-3 (δ C 131.5). Furthermore, the carbon signal of C-1 shifted upfield from δ C 168.1 (in 4) to δ C 162.5 (in 2), revealing the existence of a quinazoline fragment as in terremide B. 3 The structure of asperterrestide B (2) was determined as 3,4,5-trimethoxyl-2-(4-oxo-2-(pyridine-3-yl)-quinazolin-3(4H)-yl) benzoate.
Aspernolide E (3) was assigned the molecular formula C 24 H 22 O 7 through an analysis of its HRESIMS data, requiring 14 degrees of unsaturation. From the 1 H and 13 C NMR spectra (Table 2) 
■ EXPERIMENTAL SECTION
General Experimental Procedures. Optical rotations were determined with an MCP 300 (Anton Paar) polarimeter at 25°C. UV spectra were recorded on a U-2910 spectrometer (Hitachi). NMR spectra were recorded with an Avance 500 spectrometer (Bruker) at 500 MHz for the 1 H nucleus and 125 MHz for the 13 C nucleus. Chemical shifts (δ) are given with reference to TMS. ESIMS spectra were obtained with an Esquire 3000 Plus spectrometer (Bruker). HRESIMS data were acquired on a micro TOF-QII mass spectrometer (Bruker). Column chromatography was performed using silica gel (100−200 mesh; Qingdao Marine Chemicals) and Sephadex LH-20 (Amersham Pharmacia). HPLC was carried out on an ODS column (250 × 4.6 mm, 5 μm; Phenomenex) with a photodiode array detector (Shimadzu).
Fungal Materials. The fungal strain of Aspergillus terreus SCSGAF0162 was isolated from the tissue of the gorgonian Echinogorgia aurantiaca collected from Sanya, Hainan Province, China. The strain was identified by one of the authors (X.-Y.Z.), and a voucher specimen (A. terreus SCSGAF0162) has been deposited in the RNAM Center for Marine Microbiology, South China Sea Institute of Oceanology, Chinese Academy of Sciences.
Fermentation and Isolation. The fungal strain A. terreus SCSGAF0162 was cultivated in 10 L of liquid medium (20 g Dsorbitol, 3.0 g yeast extract, 0.3 g MgSO 4 ·7H 2 O, 10 g L-lysine, 0.5 g KH 2 PO 4 , 100 g maltose, 100 g NaCl in 1 L of water after adjusting its pH to 7.0, in 500 mL Erlenmeyer flasks each contain 200 mL of culture broth) at 28°C without shaking for one month. The fermented whole broth (10 L) was filtered through cheesecloth to separate the supernatant from the mycelia, and the mycelia were extracted three times with acetone. The acetone solution was evaporated under reduced pressure to afford an aqueous solution, which was then extracted three times with EtOAc to afford the EtOAc extract (10 g). The EtOAc-soluble part (10 g) was chromatographed on silica gel using gradient elution from 100% (v/v) CHCl 3 Preparation of the (R)-and (S)-MTPA Ester Derivatives of 1. Compound 1 (0.6 mg) was transferred to a clean NMR tube and dried completely. Deuterated pyridine (0.5 mL), R-(−)-MTPA-Cl (12 μL), and 0.2 mg of DMAP (4-dimethylaminopyridine) were added to the NMR tube under a N 2 gas stream. The reaction mixture was shaken for 5 h at room temperature to yield the (S)-MTPA ester derivative of 1 (1a). The 1 H NMR data of 1a were directly obtained from the NMR tube, and the data were assigned on the basis of HMBC correlations. In the same fashion, the (R)-MTPA ester derivative of 1 (1b) was obtained from the reaction mixture of 1 (0.6 mg) in deuterated pyridine (0. were the same in this method, the configuration of the Ile residue was not further determined.
Cytotoxicity Assay. Due to the small amount of the new compounds, only compound 1 was tested for its cytotoxicity. Cytotoxic activity was evaluated using human leukemic monocyte lymphoma U937, erythroid leukemic K562, gastric carcinoma BGC-823, acute lymphoblastic leukemia MOLT-4, breast adenocarcinoma MCF-7, and lung carcinoma A549 cell lines by the MTT method as described previously. 24 Taxol was used as positive control against the U937, K562, BGC-823, MOLT-4, Mcf7, and A549 cell lines with IC 50 values of 1.9, 4.9, 3.5, 1.8, 5.0, and 3.6 nM, respectively. Antiviral Assay. Due to the small amount of the new compounds, only compound 1 was tested for its antiviral activity. Compound 1 was tested against influenza virus strain A/WSN/33 (H1N1) (an M2-resistant strain) and strain A/Hong Kong/8/68(H3N2) (an M2-sensitive strain) by CPE assay to determine its inhibitory effect against virus replication in the cell MDCK. 25 
